201608-41-5
Chemical Structure
DR-4004
- CAS No.: 201608-41-5
- Formula:C26H30N2O
- Molecular Weight:386.53
IUPAC Name: 2a-(4-(4-phenyl-3,6-dihydropyridin-1(2H)-yl)butyl)-2a,3,4,5-tetrahydrobenzo[cd]indol-2(1H)-one
InChIKey: JBQOYPLKTTXLSQ-UHFFFAOYSA-N
SMILES: O=C1NC2=C3C1(CCCC3=CC=C2)CCCCN4CC=C(CC4)C5=CC=CC=C5
Biological Activity: DR-4004 is a 5-HT7 receptor antagonist that attenuates the decreased level of performance produced by mCPP and the performance levels after p-chloroamphetamine (PCA) lesion of the 5-HT system. DR-4004 also reverses amnesia induced by Scopolamine (HY-N0296) and Dizocilpine (HY-15084B). DR-4004 is promising for research of schizophrenia, cognitive deficits and atypical antipsychotic agents[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
DR-4004 | DR-4004 is a 5-HT7 receptor antagonist that attenuates the decreased level of performance produced by mCPP and the performance levels after p-chloroamphetamine (PCA) lesion of the 5-HT system. DR-4004 also reverses amnesia induced by Scopolamine (HY-N0296) and Dizocilpine (HY-15084B). DR-4004 is promising for research of schizophrenia, cognitive deficits and atypical antipsychotic agents. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
